Contract signed with Carna Bioscience Venn Life Sciences, part of Open Orphan plc announce the signing of a contract with Carna Bioscience (“Carna”) (www.carnabio.com) for a First In Human Clinical… read more →
Preferred Partner Agreement Venn Life Sciences (part of Open Orphan Plc), a European-focussed, rare and orphan drug consulting services platform company, is pleased to announce the signing of a preferred… read more →
Recent Scientific Publications Venn’s Medical and Methodology Team will continue to manage its commitment of working collaboratively with our clients and building on its past successes throughout 2020 (https://www.vennlifesciences.com/methodology-study-design-biostatistics-consulting/). As… read more →
Drug Development Training Course – Places available 25th-27th November 2019 – Discounted Price €1950 Our next Drug Development Training Course takes place on 25th of November at the Breda office.… read more →
Are you ready for Brexit? How will this impact your development programs from a regulatory perspective in Europe. Get updates on the EMA final move to new offices in the… read more →